Institutional Ownership Nls Pharmaceutics LTD Wt Pur C (NLSPW)
This table provides information about the institutional ownership of Nls Pharmaceutics LTD Wt Pur C (NLSPW). We have compiled data on the 7 institutions that hold shares in the stock, with a total of 481,878 shares, which have been reported (via 13F filing form) to have a value of $9,000.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Ayrton Capital LLC
Westport, CT |
Nov 13, 2023 Q3 2023 |
170,100
shares
|
$3,402
0.64% of portfolio
|
Q4 2021
New holding
|
|
|
Empery Asset Management, LP
New York, NY |
Nov 14, 2022 Q3 2022 |
150,000
shares
|
$3,000
0.23% of portfolio
|
Q1 2022
New holding
|
|
|
Clear Street LLC
|
Aug 13, 2025 Q2 2025 |
57,762
shares
|
$1,155
0.0% of portfolio
|
Q2 2025
Added 0.21%
|
|
|
Clear Street Group Inc.
New York, NY |
Nov 14, 2025 Q3 2025 |
57,762
shares
|
$1,155
0.0% of portfolio
|
Q3 2025
New holding
|
|
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
Nov 14, 2025 Q3 2025 |
45,830
shares
|
$916
0.0% of portfolio
|
Q3 2025
Added 180.6%
|
|
|
Ubs Group Ag
|
Nov 13, 2025 Q3 2025 |
424
shares
|
$8
0.0% of portfolio
|
Q3 2025
New holding
|
|
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
Aug 12, 2025 Q2 2025 |
0
shares
|
$0
100.0% of portfolio
|
Q2 2025
New holding
|